FDA Leadership Changes Reflect Budgetary, Scientific Challenges

FDA has a new chief operating officer and medical officer. The appointments reflect the challenges of a lean budget and calls for a chief scientist from the Institute of Medicine.

More from Market Access

More from Pink Sheet